Latest Strategy News

Iltani Resources has launched a $1 million Share Purchase Plan (SPP) offering existing Australian and New Zealand shareholders the chance to buy shares at a 10.4% discount following a recent $1.8 million placement. The funds will support exploration at the Orient Project and general working capital.

EVE Health Group has successfully passed all shareholder resolutions at its recent General Meeting, paving the way for its acquisition of Nextract Pty Ltd and announcing significant leadership changes.

InVert Graphite has successfully completed a $3.5 million public share offer, meeting a key condition for its ASX reinstatement and advancing its strategic acquisitions.

Locate Technologies has secured $1.45 million through a share placement and established a $2 million At-the-Market facility to boost financial flexibility, while unveiling a strategic plan to hold Bitcoin as part of its treasury management.

Vintage Energy has successfully completed a $2.1 million capital raise through fully subscribed Entitlement and Shortfall Offers, aiming to enhance gas output from its Cooper Basin fields.

Cobalt Blue Holdings has secured a pivotal three-year contract with Glencore to supply up to 50% of feedstock for its upcoming Kwinana Cobalt Refinery, marking a major step in advancing Australia's critical minerals ambitions.

Prospech Limited has successfully raised $1 million through a 50 million share placement, aiming to accelerate exploration efforts in Finland and Slovakia, with a particular focus on expanding the Korsnäs resource.

Regal Partners Limited reported a stellar 2024 with a 141% jump in average funds under management to $14.4 billion and a near tripling of net profit after tax. Strategic acquisitions and offshore expansion underpin its growth trajectory.

TruScreen Ordinary Shares Group Limited has announced a combined share purchase plan and placement to raise approximately NZD 1.78 million, aiming to accelerate its international expansion and cervical cancer screening initiatives.

TruScreen Group Limited forecasts a robust 64% increase in FY26 sales, driven by strategic market expansions and new distribution agreements. The company’s AI-enabled cervical cancer screening technology is gaining traction across emerging markets.

QEM Limited's trading suspension has been lifted immediately following its announcement of a new capital raise, signaling a pivotal moment for the company’s financial strategy.

QEM Limited has raised A$2.05 million through a strongly supported placement to accelerate its Julia Creek Vanadium and Energy Project, coinciding with the retirement of founding CEO Gavin Loyden and the appointment of Robert Cooper as his successor.